bypass

旁路
  • 文章类型: Journal Article
    目的:血运重建治疗慢性威胁肢体缺血(CLTI)后的心血管并发症是指导治疗的主要关注点。我们的目标是在CLTI患者的最佳血管内治疗与最佳外科治疗(BEST-CLI)试验中评估围手术期心脏和血管严重不良事件(SAE)。
    方法:BEST-CLI是一项前瞻性随机试验,比较了CLTI患者的手术(OPEN)和血管内(ENDO)血运重建。30天SAE,分类为心脏或血管,进行了分析。不良事件在试验中影响安全性时被定义为严重事件,需要长期住院,导致严重的残疾或失能,危及生命,或导致死亡。以每个方案的方式分析干预。
    结果:在BEST-CLI试验中,评估了850个OPEN和896个ENDO干预措施。40例(4.7%)和34例(3.8%)患者在OPEN和ENDO干预后至少经历了一次心脏SAE,分别(P=.35)。总体而言,OPEN后有53例心脏SAE(每位患者.06例),ENDO干预后有40例(每位患者.045例)。OPEN组的心脏SAE被分类为与缺血相关(50.9%),心律失常(17%),心力衰竭(15.1%),逮捕(13.2%),和心脏传导阻滞(3.8%);在ENDO组中,它们被分类为缺血(47.5%),心力衰竭(17.5%),心律失常(15%),逮捕(15%)和心脏传导阻滞(5%)。大约一半的SAE被归类为严重的OPEN和ENDO。SAE肯定或可能与OPEN和ENDO臂中的30.2%和25%的手术有关,分别为(P=2)。OPEN和ENDO血运重建后58例(6.8%)和86例(9.6%)患者发生血管SAE,分别(P=.19)。总的来说,OPEN和ENDO手术后有59例(每位患者.07例)和87例(每位患者.097例)血管SAE.OPEN组的血管SAE分为远端缺血/感染(44.1%),出血(16.9%),闭塞(15.3%),血栓栓塞(15.3%),脑血管(5.1%),和其他(3.4%);在ENDO臂中,他们是远端缺血/感染(40.2%),闭塞(31%),出血(12.6%),血栓栓塞(8%),脑血管(1.1%),和其他(4.6%)。SAE被分类为严重的OPEN占45.8%,ENDO占46%。SAE肯定或可能与OPEN和ENDO臂中的23.7%和35.6%的手术相关(P=.35),分别。
    结论:接受OPEN和ENDO血运重建的患者经历了相似程度的心脏和血管SAE。大多数与指数干预无关,但大约一半是严重的。
    OBJECTIVE: Cardiovascular complications after revascularization to treat chronic limb-threatening ischemia (CLTI) are a major concern that guides treatment. Our goal was to assess periprocedural cardiac and vascular serious adverse events (SAEs) in the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial.
    METHODS: BEST-CLI was a prospective randomized trial comparing surgical (OPEN) and endovascular (ENDO) revascularization for patients with CLTI. Thirty-day SAEs, classified as cardiac or vascular, were analyzed. Adverse events are defined as serious when they affect safety in the trial, require prolonged hospitalization, result in significant disability or incapacitation, are life-threatening, or result in death. Interventions were analyzed in a per protocol fashion.
    RESULTS: In the BEST-CLI trial, 850 OPEN and 896 ENDO interventions were evaluated. Forty (4.7%) and 34 (3.8%) patients experienced at least one cardiac SAE after OPEN and ENDO intervention, respectively (P = .35). Overall, there were 53 cardiac SAEs (0.06 per patient) after OPEN and 40 (0.045 per patient) after ENDO interventions. Cardiac SAEs in the OPEN arm were classified as related to ischemia (50.9%), arrhythmias (17%), heart failure (15.1%), arrest (13.2%), and heart block (3.8%); in the ENDO arm, they were classified as ischemia (47.5%), heart failure (17.5%), arrhythmias (15%), arrest (15%), and heart block (5%). Approximately half of SAEs were classified as severe for both OPEN and ENDO. SAEs were definitely or probably related to the procedure in 30.2% and 25% in the OPEN and ENDO arms, respectively (P = .2). Vascular SAEs occurred in 58 (6.8%) and 86 (9.6%) of patients after OPEN and ENDO revascularization, respectively (P = .19). In total, there were 59 (0.07 per patient) and 87 (0.097 per patient) vascular SAEs after OPEN and ENDO procedures. Vascular SAEs in the OPEN arm were classified as distal ischemia/infection (44.1%), bleeding (16.9%), occlusive (15.3%), thromboembolic (15.3%), cerebrovascular (5.1%), and other (3.4%); in the ENDO arm, they were distal ischemia/infection (40.2%), occlusive (31%), bleeding (12.6%), thromboembolic (8%), cerebrovascular (1.1%), and other (4.6%). SAEs were classified as severe for OPEN in 45.8% and ENDO in 46%. SAEs were definitely or probably related to the procedure in 23.7% and 35.6% in the OPEN and ENDO arms (P = .35), respectively.
    CONCLUSIONS: Patients undergoing OPEN and ENDO revascularization experienced similar degrees of cardiac and vascular SAEs. The majority were not related to the index intervention, but approximately half were severe.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:慢性威胁肢体缺血(CLTI)的治疗方法在实践模式和平衡方面存在显著差异。我们的目的是在试验之前和之后评估BEST-CLI研究者的治疗偏好。
    方法:在试验结束后和结果宣布之前,于2022年向1180BEST-CLI研究人员发送了电子60问题调查。在开放(OPEN)和血管内(ENDO)血运重建策略的临床方案中评估了研究者的偏好。将血管外科医生手术和血管内偏好与2010年在试验资助前对前瞻性研究者进行的调查进行比较。
    结果:对于2022年的调查,有效率为20.2%,由血管外科医生(76.3%)组成,介入心脏病学家(11.4%)和介入放射学家(11.6%)。大多数(72.6%)在学术实践中,39.1%在实践中超过20年。在初始CLTI工作期间,65.8%,42.6%,55.9%的受访者总是或通常下令动脉双工,计算机断层扫描血管造影,和静脉映射,分别。血管内和开放手术之间最常见的实践分布是70/30。术后,大多数报告说进行了静脉旁路的常规双工监测(99%),假肢搭桥(81.9%),血管内介入治疗(86%)。少数人报告总是或通常使用WIfI(25.8%),玻璃(8.3%),和风险计算器(14.8%)。超过一半(52.9%)的人同意“使用ENDO优先方法不会烧毁任何桥梁”的说法是错误的。干预选择受手术室或血管内套件的可用性影响,个人日程,个人技能占30.1%,18%和45.9%的受访者,分别。大多数受访者报告常规使用紫杉醇涂层球囊(88.1%)和支架(67.5%),然而,当提出安全问题时,73.3%的人改变了做法。在外科医生中,17.8%,2.9%,10.3%的人报告每年进行10次以上的替代自体静脉旁路,复合静脉复合静脉旁路,绕过踏板目标,分别。在所有干预主义者中,8%,24%,8%的人报告每年执行超过10次放射状手术,踏板或胫骨进入程序,和踏板环路血管重建。大多数(89.1%)的受访者认为CLTI团队改善了护理,然而,只有23.2%的人拥有明确的团队。在机构中,团队合作的有效性被认为是42.5%的高效。当比较血管外科医生对2010年调查的反应时,根据TASCII分类或导管偏好,首选治疗没有变化.2022年,开放手术更适合pop骨闭塞。对于临床情况,除了认为主要组织损失与主要组织损失相当的受访者比例下降外,没有差异(43.8%与31.2%)和增加ENDO对轻微组织损失的选择(17.6%与30.8%)(P<.05)。
    结论:在治疗CLTI的血管专家中有广泛的实践模式。BEST-CLI的大多数研究人员在先进的开放和血管内技术方面都有经验,并且代表了现实世界的技术专长样本。在BEST-CLI试验的十年中,血管外科医生之间的平衡总体相似。
    OBJECTIVE: There has been significant variability in practice patterns and equipoise regarding treatment approach for chronic limb-threatening ischemia (CLTI). We aimed to assess treatment preferences of Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) investigators prior to and following the trial.
    METHODS: An electronic 60-question survey was sent to 1180 BEST-CLI investigators in 2022, after trial conclusion and before announcement of results. Investigators\' preferences were assessed across clinical scenarios for both open (OPEN) and endovascular (ENDO) revascularization strategies. Vascular surgeon (VS) surgical and ENDO preferences were compared with a 2010 survey administered to prospective investigators before trial funding.
    RESULTS: For the 2022 survey, the response rate was 20.2% and was comprised of VSs (76.3%), interventional cardiologists (11.4%) and interventional radiologists (11.6%). The majority (72.6%) were in academic practice and 39.1% were in practice for >20 years. During initial CLTI work-up, 65.8%, 42.6%, and 55.9% of respondents always or usually ordered an arterial duplex, computed tomography angiography, and vein mapping, respectively. The most common practice distribution between ENDO and OPEN procedures was 70/30. Postoperatively, a majority reported performing routine duplex surveillance of vein bypass (99%), prosthetic bypass (81.9%), and ENDO interventions (86%). A minority reported always or usually using the wound, ischemia, and foot infection (WIfI) criteria (25.8%), GLASS (8.3%), and a risk calculator (14.8%). More than one-half (52.9%) agreed that the statement \"no bridges are burned with an ENDO-first approach\" was false. Intervention choice was influenced by availability of the operating room or ENDO suite, personal schedule, and personal skill set in 30.1%, 18.0%, and 45.9% of respondents, respectively. Most respondents reported routinely using paclitaxel-coated balloons (88.1%) and stents (67.5%); however, 73.3% altered practice when safety concerns were raised. Among surgeons, 17.8%, 2.9%, and 10.3% reported performing >10 annual alternative autogenous vein bypasses, composite vein composite vein bypasses, and bypasses to pedal targets, respectively. Among all interventionalists, 8%, 24%, and 8% reported performing >10 annual radial access procedures, pedal or tibial access procedures, and pedal loop revascularizations. The majority (89.1%) of respondents felt that CLTI teams improved care; however, only 23.2% had a defined team. The effectiveness of the teamwork at institutions was characterized as highly effective in 42.5%. When comparing responses by VSs to the 2010 survey, there were no changes in preferred treatment based on Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) II classification or conduit preference. In 2022, OPEN surgery was preferred more for a popliteal occlusion. For clinical scenarios, there were no differences except a decreased proportion of respondents who felt there was equipoise for major tissue loss for major tissue loss (43.8% vs 31.2%) and increased ENDO choice for minor tissue loss (17.6% vs 30.8%) (P < .05).
    CONCLUSIONS: There is a wide range of practice patterns among vascular specialists treating CLTI. The majority of investigators in BEST-CLI had experience in both advanced OPEN and ENDO techniques and represent a real-world sample of technical expertise. Over the course of the decade of the BEST-CLI trial, there was overall similar equipoise among VSs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Randomized Controlled Trial
    目的:预期的围手术期发病率是选择慢性威胁肢体缺血(CLTI)的血运重建方法的重要因素。我们的目标是在CLTI患者的最佳血管内与最佳手术治疗(BEST-CLI)试验中评估接受手术和血管内血运重建治疗的患者的全身围手术期并发症。
    方法:BEST-CLI是一项前瞻性随机试验,比较了CLTI患者的开放(OPEN)和血管内(ENDO)血运重建策略。研究了两个平行队列:队列1包括具有足够单段大隐静脉(SSGSV)的患者,而队列2包括没有SSGSV的队列。数据被查询为主要不良心血管事件(MACE-复合心肌梗死,中风,死亡),手术后30天发生非严重(非SAE)和严重不良事件(SAE)(标准-死亡/危及生命/需要住院或住院时间延长/严重残疾/失能/在试验中影响受试者安全性).根据方案进行分析(接受干预,没有交叉),并进行风险调整分析.
    结果:有1367名患者(662个开放,705ENDO)在队列1和379名患者中(188个开放,191ENDO)在队列2中。队列1中30天死亡率为1.5%(OPEN1.8%;ENDO1.3%),队列2中30天死亡率为1.3%(OPEN2.7%;ENDO0%)。开放队列1中的MACE为4.7%,ENDO为3.13%(P=.14),在队列2中,OPEN为4.28%,ENDO为1.05%(P=.15)。关于风险调整分析,对于队列1,OPEN与ENDO的30天MACE没有差异(风险比[HR]1.5;95%置信区间[CI],0.85-2.64;P=.16)或队列2(HR,2.17;95%CI,0.48-9.88;P=.31)。不同干预措施的急性肾衰竭发生率相似;在队列1中,OPEN为3.6%,ENDO为2.1%(HR,1.6;95%CI,0.85-3.12;P=.14),在队列2中,OPEN为4.2%,ENDO为1.6%(HR,2.86;95%CI,0.75-10.8;P=.12)。在队列1(OPEN0.9%;ENDO0.4%)和队列2(OPEN0.5%;ENDO0%)中,静脉血栓栓塞的发生率总体较低,组间相似。队列1中任何非SAE的发生率在OPEN中为23.4%,在ENDO中为17.9%(P=.013);在队列2中,OPEN为21.8%,ENDO为19.9%(P=.7)。队列1中任何SAE的比率为OPEN的35.3%和ENDO的31.6%(P=.15);在队列2中,OPEN的比率为25.5%,ENDO的比率为23.6%(P=.72)。最常见的非SAE和SAE类型是感染,手术并发症,和心血管事件。
    结论:在BEST-CLI中,被认为适合行下肢搭桥手术的CLTI患者在OPEN或ENDO血运重建术后有相似的围手术期并发症:对围手术期并发症风险的担忧不应成为决定血运重建策略的阻碍因素.相反,其他因素,包括恢复灌注和患者偏好的有效性,更相关。
    Anticipated perioperative morbidity is an important factor for choosing a revascularization method for chronic limb-threatening ischemia (CLTI). Our goal was to assess systemic perioperative complications of patients treated with surgical and endovascular revascularization in the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial.
    BEST-CLI was a prospective randomized trial comparing open (OPEN) and endovascular (ENDO) revascularization strategies for patients with CLTI. Two parallel cohorts were studied: Cohort 1 included patients with adequate single-segment great saphenous vein (SSGSV), whereas Cohort 2 included those without SSGSV. Data were queried for major adverse cardiovascular events (MACE-composite myocardial infarction, stroke, death), non-serious (non-SAEs) and serious adverse events (SAEs) (criteria-death/life-threatening/requiring hospitalization or prolongation of hospitalization/significant disability/incapacitation/affecting subject safety in trial) 30 days after the procedure. Per protocol analysis was used (intervention received without crossover), and risk-adjusted analysis was performed.
    There were 1367 patients (662 OPEN, 705 ENDO) in Cohort 1 and 379 patients (188 OPEN, 191 ENDO) in Cohort 2. Thirty-day mortality in Cohort 1 was 1.5% (OPEN 1.8%; ENDO 1.3%) and in Cohort 2 was 1.3% (2.7% OPEN; 0% ENDO). MACE in Cohort 1 was 4.7% for OPEN vs 3.13% for ENDO (P = .14), and in Cohort 2, was 4.28% for OPEN and 1.05% for ENDO (P = .15). On risk-adjusted analysis, there was no difference in 30-day MACE for OPEN vs ENDO for Cohort 1 (hazard ratio [HR] 1.5; 95% confidence interval [CI], 0.85-2.64; P = .16) or Cohort 2 (HR, 2.17; 95% CI, 0.48-9.88; P = .31). The incidence of acute renal failure was similar across interventions; in Cohort 1 it was 3.6% for OPEN vs 2.1% for ENDO (HR, 1.6; 95% CI, 0.85-3.12; P = .14), and in Cohort 2, it was 4.2% OPEN vs 1.6% ENDO (HR, 2.86; 95% CI, 0.75-10.8; P = .12). The occurrence of venous thromboembolism was low overall and was similar between groups in Cohort 1 (OPEN 0.9%; ENDO 0.4%) and Cohort 2 (OPEN 0.5%; ENDO 0%). Rates of any non-SAEs in Cohort 1 were 23.4% in OPEN and 17.9% in ENDO (P = .013); in Cohort 2, they were 21.8% for OPEN and 19.9% for ENDO (P = .7). Rates for any SAEs in Cohort 1 were 35.3% for OPEN and 31.6% for ENDO (P = .15); in Cohort 2, they were 25.5% for OPEN and 23.6% for ENDO (P = .72). The most common types of non-SAEs and SAEs were infection, procedural complications, and cardiovascular events.
    In BEST-CLI, patients with CLTI who were deemed suitable candidates for open lower extremity bypass surgery had similar peri-procedural complications following either OPEN or ENDO revascularization: In such patients, concern about risk of peri-procedure complications should not be a deterrent in deciding revascularization strategy. Rather, other factors, including effectiveness in restoring perfusion and patient preference, are more relevant.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:证明枕动脉(OA)-p1小脑后下动脉(PICA)旁路可以替代复杂的后循环动脉瘤。
    方法:对20个尸体标本进行远外侧开颅手术,OA是在线获得的。\'它的长度,直径,并确定了p1/p2和p3节段穿孔器的数量,还评估了尾环与小脑扁桃体位置之间的关系。PICA的起源与颅神经XI(CNXI)之间的距离,解剖后CNXI上方的缓冲区长度,完成OA-p1/p3PICA旁路所需的OA长度,并测量了p1和p3段的直径。使用旁路训练实践量表(TSIO)评估吻合的质量。
    结果:所有标本均接受了OA-p1PICA端到端旁路,并且对TSIO评分具有良好的结果,15侧接受了OA-p3PICA端到侧旁路,和其他旁路协议是不常见的。解剖后CNXI上方的缓冲区长度,PICA的原点和CNXI之间的距离,第一个穿孔器都有足够的长度。完成OA-p1PICA端到端旁路所需的OA的直接长度明显小于可用长度和OA-p3PICA端到端旁路,与OA相匹配的P1段直径。p1穿孔器的数量少于p3,OA直径等于p1段的OA直径。
    结论:OA-p1PICA端对端分流术在p3段有高尾环或解剖异常的情况下是一种可行的替代方法。
    OBJECTIVE: To demonstrate that occipital artery (OA)-p1 posterior inferior cerebellar artery (PICA) bypass can be an alternative for complex posterior circulation aneurysms.
    METHODS: A far-lateral approach to craniotomy was performed on 20 cadaveric specimens, and the OA was obtained \'in-line.\' Its length, diameter, and the number of p1/p2 and p3 segmental perforators were determined, and the relationship between the caudal loop and cerebellar tonsil position was also assessed. The distance between the PICA\'s origin and the cranial nerve XI (CN XI), the buffer length above the CN XI after dissection, the OA length required to complete the OA-p1/p3 PICA bypass, and the p1 and p3 segment diameters were all measured. A bypass training practical scale (TSIO) was used to evaluate the quality of the anastomosis.
    RESULTS: All specimens underwent OA-p1 PICA end-to-end bypass and had favorable results for the TSIO score, 15 sides underwent OA-p3 PICA end-to-side bypass, and the other bypass protocols were less common. The buffer length above the CN XI after dissection, the distance between the PICA\'s origin and the CN XI, and the first perforator were all of sufficient length. The direct length of the OA needed to complete the OA-p1 PICA end-to-end bypass was significantly less than the available length and the OA-p3 PICA end-to-side bypass, with the OA matching the p1 segment diameter. The number of p1 perforators was less than that of p3, and the OA diameter was equal to that of the p1 segment.
    CONCLUSIONS: OA-p1 PICA end-to-end bypass is a feasible alternative in cases in which p3 segment has high caudal loops or anatomic anomalies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:评估小脑后下动脉(PICA)-PICA旁路的可能性。
    方法:使用15个成人尸体头进行手术模拟,并采用远外侧入路暴露手术野。双边PICA课程,直径,观察和测量射孔器,以评估PICA-PICA旁路的可能性。
    结果:在15个标本中的7个(46.7%)中进行了PICA-PICA旁路;该程序在三个标本中很容易进行,两个有点困难,由于扁桃体和双侧扁桃体髓质(p3)节段的平行长度短之间的关系,在两个标本中很困难。在15个样本中的8个(53.3%)中,PICA-PICA旁路不可行,原因包括:1)双侧p3的口径与旁路无关,2)双侧P3在中线的距离>7mm,3)p3穿直动脉的中段限制了缓冲液的长度,和4)单尾环。
    结论:PICA-PICA旁路的可能性取决于双侧p3,口径匹配,以及由于射孔器引起的双侧尾环动员。PICA-PICA旁路的难度主要取决于小脑扁桃体与中线双侧PICA平行长度之间的关系。
    To assess the posterior inferior cerebellar artery (PICA)-PICA bypass possibility.
    Fifteen adult cadaver heads were used for surgical simulation, and the far-lateral approach was used to expose the surgical field. The bilateral PICA course, diameter, and perforators were observed and measured to evaluate the possibility of a PICA-PICA bypass.
    The PICA-PICA bypass was performed in seven (46.7 %) of the 15 specimens; the procedure was performed easily in three specimens, a little difficult in two, and was difficult in two specimens because of the relationship between the tonsil and the short parallel length of the bilateral tonsillomedullary (p3) segment. In eight (53.3 %) of the 15 specimens, PICA-PICA bypass was not feasible for reasons including 1) the caliber of the bilateral p3 was unmatched for bypass, 2) the distance of bilateral p3 in the midline was > 7 mm, 3) the middle segment of p3 perforating direct arteries limited the buffer length, and 4) single caudal loops.
    The possibility of PICA-PICA bypass was determined by the proximity of the bilateral p3, caliber match, and mobilization of the bilateral caudal loop due to the perforators. The difficulty of the PICA-PICA bypass mainly depends on the relationship between the cerebellar tonsil and the parallel length of the bilateral PICA in the midline.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    UNASSIGNED:微吻合是一项具有挑战性的技术,需要不断的训练才能掌握。已经提出了几种模型,但很少能有效反映真正的搭桥手术;可重复使用的更少,大多数都不容易接近,设置通常很长。我们的目标是验证一个简化的,随时可用,可重复使用,符合人体工程学的旁路模拟器。
    未经评估:12名新手和2名神经外科专家完成了8个“端到端”(EE),八个端到端(ES),和8个使用2毫米合成血管的侧对侧(SS)微吻合。执行旁路的时间数据(TPB),收集缝线的数量和阻止潜在泄漏所需的时间。在最后一次训练之后,参与者完成了LikertLike调查,以评估旁路模拟器。使用西北客观微吻合评估工具(NOMAT)评估每位参与者。
    UNASSIGNED:比较第一次和最后一次尝试时,3种微吻合术组的平均TPB均有改善.新手组的改善始终具有统计学意义,在专家组中,这仅对ES旁路有意义。两组的NOMAT评分均有改善,显示EE旁路新手的统计意义。平均泄漏次数,以及它们解决的相对时间,通过增加尝试,两组也趋于逐渐减少。专家表达的李克特得分略高(25对新手24.58)。
    UNASSIGNED:我们提出的旁路训练模型可能代表简化的,随时可用,可重复使用,符合人体工程学,和有效的系统,以提高眼-手协调性和灵活性进行微吻合。
    UNASSIGNED: Microanastomosis is a challenging technique requiring continuous training to be mastered. Several models have been proposed, but few effectively reflect a real bypass surgery; even fewer are reusable, most are not easily accessible, and the setting is often quite long. We aim to validate a simplified, ready-to-use, reusable, ergonomic bypass simulator.
    UNASSIGNED: Twelve novice and two expert neurosurgeons completed eight End-to-End (EE), eight End-to-Side (ES), and eight Side-to-Side (SS) microanastomoses using 2-mm synthetic vessels. Data on time to perform bypass (TPB), number of sutures and time required to stop potential leaks were collected. After the last training, participants completed a Likert Like Survey for bypass simulator evaluation. Each participant was assessed using the Northwestern Objective Microanastomosis Assessment Tool (NOMAT).
    UNASSIGNED: When comparing the first and last attempts, an improvement of the mean TPB was registered in both groups for the three types of microanastomosis. The improvement was always statistically significant in the novice group, while in the expert group, it was only significant for ES bypass. The NOMAT score improved in both groups, displaying statistical significance in the novices for EE bypass. The mean number of leakages, and the relative time for their resolution, also tended to progressively reduce in both groups by increasing the attempts. The Likert score expressed by the experts was slightly higher (25 vs. 24.58 by the novices).
    UNASSIGNED: Our proposed bypass training model may represent a simplified, ready-to-use, reusable, ergonomic, and efficient system to improve eye-hand coordination and dexterity in performing microanastomoses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    未经评估:本研究旨在评估绕过三个NiTi旋转文件的成功率(RaCe®,英雄642®,和K3®),下颌磨牙的根管位置不同,有两种不同的根管曲率。
    未经授权:选择了90颗新鲜提取的人类第一或第二下颌磨牙。三毫米的文件尖端(RaCe®,英雄642®,和K3®),通过以4%的锥度削弱#30的最后3mm中的牙根管并准备具有两种不同曲率(n=30)的根管,在每颗牙齿的近颊根管中故意骨折。然后,使用#8,#10和#15K文件评估了断裂文件的旁路可能性,并在不同组中进行了比较.此外,比较了这些组的意外程序错误发生率.采用单因素分析和logistic回归模型对数据进行显著性水平为0.05的分析。
    UNASSIGNED:旁路的总体成功率为61.1%。RaCe®文件最高,K3®文件最低(P=0.01);运河弯曲程度越大,旁路手术越不成功(P=0.01)。用于绕过的文件的断裂是最普遍的错误。
    UNASSIGNED:基于这项体外研究,断裂文件的类型和运河弯曲量影响了旁路技术的成功率。在RaCe®文件和轻度曲率组中,成功率最高。
    UNASSIGNED: This study aimed to evaluate the success rate of bypassing three NiTi rotary files (RaCe®, Hero 642®, and K3®), fractured in various root canal locations of extracted mandibular molars with two different canal curvatures.
    UNASSIGNED: Ninety freshly extracted human first or second mandibular molars were selected. Three millimeters of the file tip (RaCe®, Hero 642®, and K3®), was fractured intentionally in the mesiobuccal root canal of each tooth by weakening the file in the last 3 mm of files #30 with 4% taper and preparing the root canals with two different degrees of curvature (n=30). Then, bypass possibility of the fractured files was evaluated using #8, #10, and #15 K-files and compared in different groups. In addition, the rate of accidental procedural errors was compared between these groups. Data were analyzed with univariate analysis and logistic regression models at a significance level of 0.05.
    UNASSIGNED: The overall success rate of bypassing was 61.1%. RaCe® files had the highest and the K3® files had the lowest bypass possibility rates (P=0.01); the greater the degree of canal curvature, the less successful the bypass procedure (P=0.01). The fracture of the files used to bypass was the most prevalent error.
    UNASSIGNED: Based on this in vitro study the type of fractured file and the amount of canal curvature affected the success rate of the bypassing technique. In RaCe® files and the mild curvature group, the success rate was the highest.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:胃食管反流病(GERD)是袖状胃切除术(SG)的重要并发症。腹腔镜Roux-en-Y胃旁路术(LRYGB)被认为是患有GERD的减肥手术候选人的主要治疗方法。GERD的术后管理选择有限。这项研究比较了GERD患者在SG和LRYGB之前经口胃底折叠(TF)的效果。
    方法:在2018年3月22日至2020年6月23日期间连续30例GERD减重手术患者中,15例患者在SG之前接受TF(TF/SG),15例患者接受LRYGB。主观和客观标准,包括GERD健康相关生活质量(HRQL)和反流症状指数(RSI)调查,用于评估症状。术前收集调查,post-TF/pre-SG,减重手术后4-6个月和12-15个月。
    结果:术前平均评分如下:HRQL32.53,RSI21.7,93%质子泵抑制剂(PPI)的使用,6.5%的满意率。平均BMI:45.99(TF/SG),42.27(LRYGB)。术后12-15个月:平均HRQL评分分别为5.53(TF/SG)和6.67(LRYGB)。两组术后HRQL-RSI均有统计学意义的改善。PPI使用率分别为13%(TF/SG)和34%(LRYGB)。BMI下降24%(TF/SG)和31%(LRYGB)。
    结论:TF/SG在缓解或减轻12-15个月时的反流症状方面至少等同于LRYGB。
    Gastroesophageal reflux disease (GERD) is a significant complication of sleeve gastrectomy (SG). Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) is considered the primary treatment for bariatric surgery candidates with GERD. Post-operative options for GERD management are limited. This study compares the effect of transoral fundoplication (TF) prior to SG vs LRYGB in patients with GERD .
    Of 30 consecutive bariatric surgery patients with GERD between 3/22/2018 and 6/23/2020, 15 patients underwent TF prior to SG (TF/SG) and 15 patients underwent LRYGB. Subjective and objective criteria, including the GERD Health-Related Quality of Life (HRQL) and Reflux Symptom Index (RSI) survey, were used to assess symptoms. Surveys were collected pre-operatively, post-TF/pre-SG, 4-6 and 12-15 months post bariatric procedure.
    Preoperative mean scores were as follows: HRQL 32.53, RSI 21.7, 93% proton pump inhibitor (PPI) usage, 6.5% satisfaction rate. Mean BMI: 45.99 (TF/SG), 42.27 (LRYGB). At 12-15 months postoperatively: mean HRQL scores were 5.53 (TF/SG) and 6.67 (LRYGB). Both groups had a statistically significant improvement in HRQL-RSI postoperatively. PPI usage was 13% (TF/SG) and 34% (LRYGB). BMI decrease was 24% (TF/SG) and 31% (LRYGB).
    TF/SG is at least equivalent to LRYGB in resolution or reduction of reflux symptoms at 12-15 months.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    冠状动脉搭桥术(CABG)手术后的医疗保健利用率很高,部分是计划外的。已经提出了电子健康应用来减少护理消耗,这涉及并帮助患者康复。这样,医疗费用可以降低,医疗质量可以提高。
    这项研究的目的是评估电子健康计划是否可以在CABG手术后的前6周内减少计划外的医疗保健利用并改善身心健康。
    进行了一项单盲随机对照试验,其中计划在2020年2月至2021年10月期间接受非急性CABG手术的患者来自荷兰的一个中心.干预组的参与者,除了标准护理,获得电子健康计划,包括与荷兰心脏基金会共同开发的在线教育视频和视频咨询。对照组接受标准护理。主要结果是计划外医疗保健利用的综合数量和成本,包括急诊,门诊就诊,再住院,患者发起的电话咨询,去看全科医生,使用医疗技术评估医疗消费问卷进行测量。还评估了患者报告的焦虑和恢复情况。使用意向治疗和“仅用户”分析。
    在研究期间,280名患者被纳入并以1:1的比例随机分配到干预组或对照组。意向治疗分析包括干预组和对照组的136例和135例患者,分别。在6周,主要终点发生在干预组136例患者中的43例(31.6%)和对照组135例患者中的61例(45.2%)(风险比0.56,95%CI0.34~0.92).干预组恢复更快,而研究组之间的焦虑相似.“仅限用户”分析产生了类似的结果。
    包含教育视频和视频咨询的eHealth策略可以减少计划外的医疗保健利用,并有助于CABG手术后患者更快的患者报告康复。
    荷兰试验登记处NL8510;https://trialsearch。谁。int/Trial2。aspx?试验ID=NL8510。
    RR2-10.1007/s12471-020-01508-9.
    Health care utilization after coronary artery bypass graft (CABG) surgery is high and is partly of an unplanned nature. eHealth applications have been proposed to reduce care consumption, which involve and assist patients in their recovery. In this way, health care expenses could be reduced and quality of care could be improved.
    The aim of this study was to evaluate if an eHealth program can reduce unplanned health care utilization and improve mental and physical health in the first 6 weeks after CABG surgery.
    A single-blind randomized controlled trial was performed, in which patients scheduled for nonacute CABG surgery were included from a single center in the Netherlands between February 2020 and October 2021. Participants in the intervention group had, alongside standard care, access to an eHealth program consisting of online education videos and video consultations developed in conjunction with the Dutch Heart Foundation. The control group received standard care. The primary outcome was the volume and costs of a composite of unplanned health care utilization, including emergency department visits, outpatient clinic visits, rehospitalization, patient-initiated telephone consultations, and visits to a general practitioner, measured using the Medical Technology Assessment Medical Consumption Questionnaire. Patient-reported anxiety and recovery were also assessed. Intention-to-treat and \"users-only\" analyses were used.
    During the study period, 280 patients were enrolled and randomly allocated at a 1:1 ratio to the intervention or control group. The intention-to-treat analysis consisted of 136 and 135 patients in the intervention and control group, respectively. At 6 weeks, the primary endpoint had occurred in 43 of 136 (31.6%) patients in the intervention group and in 61 of 135 (45.2%) patients in the control group (hazard ratio 0.56, 95% CI 0.34-0.92). Recovery was faster in the intervention group, whereas anxiety was similar between study groups. \"Users-only\" analysis yielded similar results.
    An eHealth strategy comprising educational videos and video consultations can reduce unplanned health care utilization and can aid in faster patient-reported recovery in patients following CABG surgery.
    Netherlands Trial Registry NL8510; https://trialsearch.who.int/Trial2.aspx?TrialID=NL8510.
    RR2-10.1007/s12471-020-01508-9.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号